A s in North America, 1 cardiovascular disease (CVD) and its most common manifestation, heart disease, affect more Australian adults than any other disease type and is a considerable and growing burden on the healthcare system. 2 This is largely attributable to the increasing number of older individuals surviving an acute cardiac event 3 but with residual risk for subsequent (often costly) events. Unfortunately, despite expert recommendations to prevent disease progression, 4 there are still significant gaps in the overall application of gold-standard secondary prevention. Apart from practical issues, such as ready access to prevention programs after an acute cardiac event, 5 individual factors, such as treatment nonadherence, poor knowledge, poor health literacy, and suboptimal self-care behaviors, 6 may undermine the longer term impact of traditional (and predominantly short-term) cardiac rehabilitation programs. 7 The cornerstones of these programs include key pharmacological agents, including antiplatelet therapy, angiotensin-converting enzyme inhibitors, and β-blockers and nonpharmacological strategies to promote regular exercise, weight reduction, and healthier dietary patterns. 8 We have identified a gap between the proven benefits of short-term secondary prevention programs after an acute Background-We examined the impact of a prolonged secondary prevention program on recurrent hospitalization in cardiac patients with private health insurance.
Study Hypothesis
We tested the hypothesis that a prolonged secondary prevention program delivered via a nurse-led, multidisciplinary, home-based intervention (HBI) would reduce the rate (and cost) of all-cause hospital stay during 2 to 3 years follow-up by a minimum of 20% relative to usual postdischarge care (UC).
Methods
A detailed description of the rationale and design of the Young at Heart Study that conforms to the principles outlined in the Consolidated Standards of Reporting Trials (CONSORT) guidelines for pragmatic trials 12 has been published previously. 10 The study had approval from the Ethics Committee of Uniting Care Health (the notfor-profit owners of the 2 hospitals) and conforms to the principles of the Declaration of Helsinki. All patients provided written informed consent to participate.
Study Setting
Australia's healthcare system provides universal access to hospital treatment alongside subsidized out-of-hospital medical treatment (Medicare). Fee-for-service private health care facilities are available to all Australians but predominantly used by those with private health insurance plans (estimated 44% of Australia's ≈22 million population). 13 Such individuals tend to use more healthcare resources with greater frequency (eg, primary care consultations and elective hospital procedures). 14 
Study End Points
The primary end point was the rate of all-cause hospital stay during a mean of 31.5±7.5 months follow-up (calculated and presented as days per patient per month of follow-up) after an index cardiac hospitalization. End point data were censored on December 30, 2011. Secondary end points included the following: (1) the clinical status of patients at 2 years follow-up according to the Green Amber Red Delineation of Risk and Need (GARDIAN) classification system, 15 (2) rate of all-cause and cardiovascular-related hospitalization, (3) event-free survival (from death or hospitalization), (4) all-cause mortality, (5) quality of life, and (6) healthcare costs (this report describes the primary cost of hospitalization only, full health economic analysis of cost data are pending). In brief, the GARDIAN system comprises individual assessment of risk and need that modulates the frequency and intensity of future healthcare intervention. Individual assessment of risk and need for ongoing intervention and support is determined with reference to 3 domains: (1) clinical stability, (2) gold-standard management, and (3) a broader, holistic assessment of individual circumstance. 15 All end points were analyzed in a blinded fashion. Consistent with previous studies, 16 hospital coding (ie, cause of admission) was independently determined from hospital records and reimbursement of private healthcare and Medicare copayments according to diagnostic-related groupings. This included Bupa health insurance claims data that captured all inpatient admissions and procedures in private hospitals, public copayments made by Medicare Australia, and patient out-of-pocket costs. Equivalent data were collected for public hospital admissions (minority of cases). Study end points were subject to post hoc, sex-specific analyses.
Selection Criteria
All patients admitted to the participating hospitals were screened for study eligibility according to the following criteria: (1) ≥18 years of age, (2) discharged to home with any cardiac diagnosis (confirmed by a cardiologist) requiring ongoing management, and (3) private health cover with Bupa Australia. Potentially eligible patients were excluded if they were the following: (1) living outside a 45-km radius of the participating hospital, (2) diagnosed with a terminal condition, (3) non-English speaking, (4) incapable of providing informed consent, or (5) treated by cardiologist who refused to participate.
Randomization
Group allocation (computer-generated random allocation sequence, with block randomization for the 2 hospitals) was applied, in a blinded fashion by the Baker IDI management group, to group assign patients on a 1:1 basis.
Study Data
Detailed demographic and clinical data were collected at baseline by dedicated study personnel. All patients received interim phone calls at 6 and 18 months to determine their general health status. At baseline, a number of validated tools/clinical scales were applied on a face-toface basis by trained personnel to measure health-related quality of life (Medical Outcome Study [MOS] SF-12 17 and EQ-5D), 18 cognitive function (Montreal Cognitive Assessment Tool), 19 mental health status (the 2-item Arroll screening tool to identify potential depression 20 followed by, only if answered positively, the CES-Depression Scale), 21 and angina and breathless symptoms (Canadian and New York Heart Association functional class, respectively). All surviving patients were subject to clinical follow-up, and the same tools/clinical scales applied at 24 months postindex admission.
Usual Postdischarge Management
Consistent with the nature of the Australian healthcare system and the private healthcare status of participants, patients in the
WHAT IS KNOWN
• Cardiovascular disease and its most common manifestation, heart disease, remain a considerable and growing burden on the global healthcare system. • The benefits of short-term cardiac rehabilitation programs for survivors of acute coronary syndrome are well described. However, the potential costbenefits of more prolonged and inclusive secondary prevention for high-risk individuals with cardiac disease, particularly in various healthcare systems, are less clear.
WHAT THE STUDY ADDS
• We examined the longer term impact of a nurse-led, secondary prevention program on recurrent hospitalization in high-risk cardiac patients with private health insurance and ready access to specialist support in Australia. • Compared with usual care, home-based intervention did not reduce recurrent all-cause hospitalization. However, post hoc analyses suggest some benefits in cardiac outcomes for men but not for women.
UC group had ready access to follow-up healthcare services. This typically included ongoing care by their treating specialist physician and a family physician with specialist follow-up as clinically indicated. For example, those discharged with an acute coronary syndrome had access to each hospital's short-term cardiac rehabilitation program.
Study Intervention
The study intervention was applied by 2 experienced cardiac nurses at each hospital who received standardized training on the study protocol and intervention before study commencement. The main vehicle used to gather key information about the patient was a comprehensive home visit within 7 to 14 days postindex hospitalization according to the previously described GARDIAN system. 15 On this basis, patients were designated as low (green), medium (amber), or high (red) risk (the traffic light system) for a preventable cardiovascular event (hospitalization or death) using prospectively applied criteria. Intensity of subsequent management by the cardiac nurse, including repeat home visits, telephone coaching, 22 and referral to other health professionals and programs (including hospital-based cardiac rehabilitation), was adjusted accordingly. A detailed clinical report and recommended actions were then sent to the patient's specialist and family physician. In the longer term, HBI patients were able to contact the cardiac nurse for continued advice and support, and, if readmitted to hospital, a repeat home visit at 7 to 14 days was implemented, accompanied by the preparation of a revised healthcare plan. Figure 2 provides a graphical representation of patient management during the study. 23
Statistical Analyses
Using data from Bupa Australia health insurance claims data and studies of the impact of HBI relative to UC in Young at Heart equivalent patients in the public healthcare system, we calculated that a minimum of 600 patients (1:1 group allocation) would provide >85% study power (2-sided α of 0.05) to detect an absolute 20% difference in the primary outcome (expected rate of 0.42±0.33 days of hospitalization/patient per month in the UC group) whereas permitting up to 10% loss to follow-up. 10 Sex-specific analyses of outcome data were performed on a post hoc basis after initial analysis of hospital activity and survival. All study analyses were blinded to study allocation and undertaken on an intention-to-treat basis using SPPS 17.0 and Stata 11 statistical package. Continuous data are presented as a mean±SD for normally distributed data or as a median and interquartile range (IQR) if nongaussian distributed. Categorical data are presented as an absolute number (with proportions and 95% confidence intervals [CIs]). Between group (univariate) comparisons of baseline characteristics and 2-year clinical status were assessed by Student t tests, Mann-Whitney U test (for non-normally distributed continuous data), and χ 2 test (with calculation of odd ratio's [OR] and 95% CIs) where appropriate. All event rates were highly skewed. Differences between event rates per month by group (including the primary end point) were assessed using generalized linear models. Both log Poisson and log γ generalized linear models were attempted. However, according to the Bayes Information Criteria, the γ regression model provided a much better fit to the data. Given highly skewed data, effect size estimates (ESEs) were based on ranked data and calculated by subtracting the mean rank for each group and dividing by the pooled within SD of the ranks 24 ; 95% CI for the effect sizes were estimated by simulation based on a noncentral t distribution. 25 Hospital costs were calculated per patient per month of study follow-up, adjusted for inflation, and expressed in 2011/2012 Australian dollars (AU$1.00≈US$1.00). The cost analysis was taken from the perspective of the health insurer (Bupa Australia). Kaplan-Meier survival curves were initially generated from allcause mortality and event-free survival data and analyzed with the log-rank test to determine potential group differences. Cox proportional hazards models and survival curves were then constructed to examine the independent impact of group allocation on the following: (1) event-free survival from all-cause death or hospitalization, (2) all-cause mortality, and (3) event-free survival from cardiovascular-related hospitalization. For all models, months of follow-up were used as the exposure variable. Baseline profiling data were included in the model if the univariate P value was <0.1 and retained (on a step-wise, backward basis) if the adjusted P value was <0.1 with forced entry of group allocation. Hazard plots were reviewed by the Study Statistician to confirm appropriate assumption of proportional hazards. Table 1 shows the baseline demographic and clinical profile of the cohort according to group. The groups were well balanced except that more patients in HBI lived alone (P<0.05). Mean age was 70±10 years, the majority of participants were men (72%), and many were hospitalized for coronary artery disease (62%), of whom 39% underwent coronary revascularization. Women were on average 5 years older (P<0.001) and had greater levels of comorbidity (P=0.009) than men; these differences were consistent across the 2 study groups.
Results

Baseline Profile
Postdischarge Management
Overall, 293 patients (96% of those allocated to HBI) received a baseline home visit within 7 to 14 days of hospital discharge; 13 other patients had died or withdrew consent to the home visit. Overall, 40 (14%), 204, (70%), and 49 (17%) HBI patients were assessed as requiring high (red), medium (amber), and low (green) levels of surveillance and management according to our GARDIAN criteria. Clinical instability (in the high-intensity follow-up group only) typically involved recurrent ischemia, syncope, and signs of acute heart failure. Potential contributory factors in the high-and medium-intensity follow-up groups included areas of deficit with respect to the following: (1) their pharmacological therapy, particularly those providing optimal secondary prevention, such as antiplatelet therapy and angiotensin-converting enzyme inhibitors; and (2) uncontrolled risk factors, including obesity complicated by sedentary lifestyle and poor dietary habits. As assessed by the cardiac nurses, the low-intensity follow-up group was clinically stable, was appropriately managed, and had few risk factors for future adverse events overall.
In response, the cardiac nurses initiated a range of interventions to supplement the mandatory home visit. This included referral to a cardiac rehabilitation program (n=153; 52%) and a dietician (n=47; 16%). It also involved (for amber and red designated patients only) a recommendation for the patient's general practitioner to initiate a chronic disease management plan (n=134; 46%), with additional telephone coaching to agreed risk targets by the cardiac nurses (n=145; 49%). Consequently, additional home visits were performed in 3 (6.1%), 25 (12%), and 20 (50%) patients designated green, amber, or red status for follow-up. Accordingly, the equivalent rate of phone calls was 1.8, 2.1, and 7.7 per patient, respectively, in these groups with an overall rate of 3.3 calls per patient (average duration 7.5 minutes).
Primary End Point: All-Cause Hospital Stay
During a mean of 31.5±7.5 months follow-up, 492 (82%) patients accumulated 2397 all-cause hospitalizations and 10 258 days of hospitalization. Of these, 530 (22.1% of total hospital activity) hospitalizations, representing 4470 (43.6%) days and $5.3 million costs (30.6%), were unplanned, with 253 (42%) patients experiencing an unplanned hospitalization. Table 2 summarizes major forms of hospital activity for the 2 groups. Total levels of activity were similar (no significant differences) with 1197 HBI versus 1200 UC all-cause hospitalizations associated with 5405 versus 4853 days, respectively, of hospital stay. Overall, there was no difference in 
All-Cause Mortality
A total of 42 (7.0%; 95% CI, 5.2%-9.3%) patients died comprising 27 
Event-Free Survival
Overall, 138/306 HBI (45.1%; 95% CI, 39.6%-50.1%) versus 133/296 (44.9%; 95% CI, 39.4%-50.6%) experienced an (all-cause) unplanned readmission or death with a slightly higher adjusted risk of such an event for the HBI group (HR, 1.03; 95% CI, 0.78-1.30; P=0.771). Alternatively, fewer HBI (70/306; 22.9%; 95% CI, 18.5%-27.9%) versus UC (81/296; 27.4%; 95% CI, 22.6%-32.7%) patients experienced an unplanned cardiovascular admission. Figure 3 compares the adjusted event-free survival curves (from unplanned hospitalization or death) for the 2 groups. Independent correlates of such an event were advanced age, increasing comorbidity (Charlson Index of Comorbidity Score), 26 length of index admission, and presence of depressive symptoms. Figure 3 also compares the adjusted event-free survival curves from an unplanned cardiovascular hospitalization. Independent correlates of cardiovascular admission were living alone (HR, 1.62; 95% CI, 1.03-2.54; P=0.038) and increasing comorbidity (HR, 1.09; 95% CI, 1.02-1.16 per unit score; P=0.013).
Sex-Based Comparisons in Hospital Activity
Differential patterns of healthcare use according to group assignment and sex were immediately apparent, and a series of post hoc analyses were performed to determine the extent of observed differences. Table 3 summarizes the pattern of hospital activity for men and women separately. There was a consistent (but nonsignificant) trend for more hospital activity for all forms of hospitalization in the HBI as compared with the UC group in women. Adjusting for the duration of follow-up, this resulted in a higher rate (per patient per month) of the following: (1) In women, observed differences were largely mediated by ≈13% more women hospitalized for an elective admission with 25 more hospitalizations and 456 more days of hospital stay. In men only, marked differences in the pattern of cardiovascular admissions reached borderline and statistically significant levels relative to UC with 77 fewer hospitalizations (P=0.054; ESE, 0.15 [95% CI, 0.08-0.49]), 648 fewer days of admission (P=0.114; ESE, 0.13 [95% CI, 0.08-0.49]), and >$1 million reduced costs (P=0.046; ESE, 0.12 [95% CI, 0.08-0.49]). Figure 4 demonstrates the reverse trends with respect to group allocation and event-free survival from an unplanned hospitalization or death (lower curves) or an unplanned cardiovascular hospitalization (upper curves). In contrast to men assigned to the HBI (HR, 0.68; 95% CI, 0.46-0.99; P=0.044), women in the HBI group were 1.59-fold (95% CI, 0.93-2.57; P=0.091) more likely to experience an unplanned cardiovascular hospitalization relative to UC. In men, advancing age was associated with a reduced likelihood of an unplanned cardiovascular readmission (HR, 0.97; 95% CI, 0.94-1.00 per year; P=0.05), whereas in women, it was associated with an increased likelihood (HR 1.06, 95% CI, 1.01-1.10 per year; P=0.012). In women only, study site (HR, 0.57; 95% CI, 0.40-0.82, site A versus B; P=0.002) was also an independent factor in determining the risk of such an event. Consistent with this pattern, of the 20 patients (3.3%) who were hospitalized for a cerebrovascular event (predominantly ischemic stroke), only 2 were HBI men (versus 11 UC men; P=0.021); overall comparison 5 HBI versus 15 UC men and women patients (OR, 0.32; 95 CI, 0.12-0.88; P=0.022). A similar but less striking pattern was observed in relation to acute coronary syndromes with 23 HBI versus 35 UC patients (comprising 13 HBI versus 27 UC men; P=0.030) hospitalized on this basis; OR, 0.64; 95% CI, 0.39 to 1.05 for HBI versus UC; P=0.097. 
Clinical Status at 2 Years
A total of 257 HBI and 262 UC patients (93% of survivors overall) were reassessed at 2 years. Table 4 summarizes their health status according to study group. Similar improvements in the risk factor and clinical profiles of both groups were observed with respect to prescribed pharmacotherapy. Fewer HBI compared with UC patients were assessed as high (6% versus 11%) or medium (55% versus 61%) risk for future CVD event in the longer term (combined 61% versus 72%; OR, 0.49; 95% CI, 0.26-0.94; P=0.031 for combined classification). Consequently, more HBI than UC patients (39% versus 28%; OR, 1.67; 95% CI, 1.15-1.41; P=0.007) were assessed as requiring only routine surveillance/management in the longer term. 
Discussion
We examined the impact of a longer term (2-year follow-up) nurse-led, multidisciplinary, home-based secondary prevention program in privately insured cardiac patients with ready access to specialist care after an index hospitalization. This represents 1 of the largest (and most comprehensive) studies of its type. Relative to usual postdischarge management typically provided to privately insured patients in Australia that comprised specialist physician care and ready access to cardiac rehabilitation, we found no significant differences in the primary end point of rate of hospital stay during 2 to 3 years follow-up. Moreover, there were no statistically significant differences in event-free survival (death or hospitalization) or any hospitalization parameters. Indeed some end points favored the UC group, although this seemed to be largely confined to women participants (see below). More positively, HBI participation rates were very high, as was follow-up participation among survivors at 2 years for a comprehensive clinical review. Despite improvements in both groups with respect to their risk factor and clinical profiles from baseline to 2 years, HBI was associated with more favorable overall health and future risk profiles. However, this did not translate to better health outcomes but might in the future for the HBI group. The sex-based differentials in health outcomes were immediately apparent, and our post hoc analyses confirmed almost opposite results for men and women. This was particularly true for CVD-related events with significant/borderline differences in favor of HBI with respect to risk of unplanned CVD hospitalization, number of CVD hospitalizations, and associated costs. The net effect of a differential and highly consistent impact of the Young at Heart program among men and the fewer women participants was a neutral outcome overall.
A number of broadly equivalent studies and systematic reviews of the literature focusing on the benefits of homebased, predominantly nurse-led, multidisciplinary care have revealed improved health outcomes in both cardiac 27 and noncardiac patient cohorts. 28 The strength of evidence in favor of such an approach is largely focused on hospitalized patients with CHF, 9 with our own recent study of home versus clinicbased management of CHF favoring the home intervention with respect to reduced hospital stay and healthcare costs. 16 We have previously demonstrated that when excluding patients with chronic pulmonary disease in a cohort of chronically ill patients being managed within the public health system of Australia (characterized by far less hospital activity and in particular elective hospitalizations), a more transient form of HBI was associated with an approximate one-third reduction in recurrent all-cause hospital stay. 29 The impact of HBI was particularly striking with respect to CVD events with significantly fewer admissions for CHF (de novo), acute coronary syndrome, and stroke. 29 However, there have been contemporary randomized trials of management programs focusing on both low-risk 30 and high-risk CHF patients 31 that have failed to demonstrate health benefits relative to UC. The results of the Coaching Patients on Achieving Cardiovascular Health Study 31 are particularly relevant given that a similar program of postdischarge management was compared with the care of cardiologists for patients with CHF. It has been postulated that the quality of care provided by cardiologists is difficult to improve on. Similarly, in this study, patients in UC were managed by their specialists and had ready access to gold-standard care. Although our baseline assessments (in the HBI group) and at 2 years (both groups) revealed deficits in optimal secondary prevention, favorable differences in the HBI group did not translate into reduced morbidity or mortality.
Beyond the difficulty of improving on high standards of health care, there are a number of potential reasons for the lack of expected benefits seen in favor of HBI. First, given that we exclusively recruited hospitalized cardiac patients, we anticipated a significant component of future hospitalizations would be CVD-related and unplanned. Hospital activity levels were far higher than expected, and these were predominantly elective and noncardiac in nature. As such, one might question both the primary end point (all cause) and possible impact of HBI on noncardiac and elective admissions (particularly with previous evidence showing that HBI tends to increase elective admissions). 29 Moreover, in the early stages of designing this study, we flagged the potential to invoke the phenomenon of clinical cascade whereby more detailed care and attention lowers admission thresholds and increases hospital activity. 32 Given high levels of participation and trends in elective admissions, we cannot discount this possibility. Moreover, by operating within a private healthcare setting, we were unable to control the actions of the consultant physicians and supportive healthcare services.
Without underestimating the aforementioned factors, it is difficult to ignore sex-based differences. Despite previous research supporting the application of secondary prevention programs in women, 33 it seems that predominantly older and more fragile women participants in this study did not benefit from HBI, whereas men received some benefits. If observed sex-based differences represent a true reflection of the differential impact of the program, there is a clear need to understand why this happened. It is worth noting that our findings are not unprecedented. In the Montreal Heart Attack Readjustment Trial, 34 Frasure-Smith and colleagues surprisingly found worse health outcomes in women and little impact on men assigned to the study intervention group. 35 They postulated that the intervention (mainly telephone based) provoked increased stress/distress in participants (particularly women), and we cannot discount a similar phenomenon in this study.
As with any pragmatic study, a number of limitations require comment. Consistent with other forms of health service research, we were unable to blind the study intervention. We also largely relied on healthcare records and reimbursement items from Bupa to determine the nature and cause of Health-related quality of life was measured in 256 UC and 254 HBI patients, poor dietary habit (n=258 and 254) and MOCA (n=248 and 239) overall. SF-12 domains have a scoring range of 0-100 (expected mean of 50 with higher scores indicating better quality of life). The EQ-5D has a scoring range of 0-1.0 (perfect health). Potential depression was derived from a positive response to the 2-item Arroll tool (CES-D data are not presented). The MOCA tool is scored from 0-30 with scores >26 indicative of intact cognitive function. ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; GARDIAN, Green Amber Red Delineation of Risk and Need; HBI, home-based intervention; MOCA, Montreal Cognitive Assessment tool; NYHA, New York Heart Association; 6MWT, 6-minute walk test; and UC, usual postdischarge care.
hospitalizations, although this ensured minimal loss to followup. Given the heterogeneous cohort and pragmatic nature of the study, we were unable to standardize clinical profiling data, and the potential confounders of differential cardiac interventions rates and pharmacotherapy for men and women cannot be discounted. With respect to external validity, given that Australia's hybrid public/private healthcare system differs from many other countries, the results of this study need be interpreted with some caution. Moreover, our exploration of sex-based differences was based on post hoc analyses, and we are yet to present a complete health economic analysis of all healthcare activity during follow-up. To confirm our findings, we would need to undertake repeat studies of similar study size but comprising men and women only.
In this large, multicenter, randomized trial of a nurse-led, HBI (the Young at Heart Program) applying secondary prevention to recently hospitalized cardiac patients with ready access to specialist physicians and treatment, we found no difference in hospital activity levels between HBI and UC during 2 to 3 years follow-up. Positive results with respect to optimal secondary prevention at 2 years may yet yield positive results in favor of HBI in the longer term. Alternatively, sex-based differentials in outcomes (HBI favoring men but not women) need to be cautiously interpreted and require further investigation to confirm their veracity.
